Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
8don MSN
First-in-human trial of CRISPR gene-editing therapy safely lowers cholesterol and triglycerides
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...
Hosted on MSN
Penn CRISPR science is the foundation for a gene-editing heart disease treatment under Eli Lilly
What if a heart attack and lifetime of statin drugs could be avoided with a one-time, two-hour infusion? Kiran Musunuru, a University of Pennsylvania cardiologist and leading gene-editing researcher, ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
The Oak Ridger on MSN
Can microbes thrive under industrial conditions to make biofuel?
Scientists are genetically engineering microbes to withstand industrial conditions for biofuel production. Researchers found that partially suppressing genes in cyanobacteria improved their growth ...
By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...
The worldwide pandemic has threatened many of the businesses you rely on every day, but don’t let it take away your source for local news. Now more than ever, we need your help to ensure nothing but ...
4don MSNOpinion
Ethics should lead, not play catch-up, expert emphasizes as Japan panel OKs making human embryos from stem cells
A leading bioethicist at Hiroshima University is calling for an anticipatory, rather than reactive, approach to ethics after ...
In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback